RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Lesley Fallowfield et al.|Cancer Epidemiology Biomarkers & Prevention|2017Cited by 6